These batokines including Nrg4 have been shown to improve metabolic diseases such as NAFLD, atherosclerosis, and diabetes (Cereijo et al., 2020; Spann et al., 2021; Liu et al., 2022). This evidence concerns the gene NRG4 and metabolic disease.